Bacterial Toxin Research Citations

February 19, 2025

Biorxiv : The Preprint Server For Biology

Sánchez-Martínez, E;Rondeau, LE;Garrido-Romero, M;da Luz, BB;Haas, DA;Yuen, G;Hall, P;Dang, R;Wang, XY;Moreno-Serna, L;López-Sanz, C;Nuñez-Borque, E;Garrido-Arandia, M;Diaz-Perales, A;Carrasco, YR;Koenig, JFE;Walker, TD;Jordana, M;Verdu, EF;Surette, MG;Ojeda, P;Vega, F;Blanco, C;Shreffler, WG;Patil, SU;Moreno, FJ;Jiménez-Saiz, R;Caminero, A;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

ere sensitized to PN using distinct techniques. 1. Intra-gastric 1038 sensitization: mice were provided 3.25 mg of crude PN extract (CPE; Greer Laboratories 1039 Inc) and 0.625 µg of cholera toxin (List Biological Laboratories) in 0.1 mL of PBS by oral 1040 gavage once a week for 6 weeks; 2. Intra-peritoneal sensitization: mice were provided 1041 3.25 mg of CPE and 6.25 µg

February 19, 2025

Journal Of Biomedical Science

Zeng, Q;Guo, H;Tang, N;Renavikar, PS;Karandikar, NJ;Lovett-Racke, AE;Racke, MK;Yan, C;Tang, R;Sinha, S;Ghosh, K;Ryal, JP;Ouyang, S;Chen, M;Amari, F;Vincenzo, C;Pope, RM;Li, Y;Yang, H;Langdon, WY;Zhang, J;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

ium tuberculosis strain H37Ra was obtained from Difco. Myelin oligodendrocyte glycoprotein peptide 35-55 was obtained from GL Biochem. Pertussis toxin was obtained from List Biological Laboratories. DNase I was obtained from Roche. Cycloheximide (CHX) was obtained from Thermo Scientific. Protein A Sepharose CL-4B was obtained from GE Health Care. Polybrene

February 17, 2025

Journal Of Neuroimmunology

Kuo, PC;Zhao, Z;Scofield, BA;Paraiso, HC;Yu, II;Brown, DA;Yen, JJ;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

purchased from BioLegend (San Diego, CA). Mycobacterium tuberculosis H37 RA was purchased from BD Biosciences (San Jose, CA). Pertussis toxin was purchased from List Biological Labs (Campbell, CA). Percoll was purchased from GE Healthcare Life Sciences (Pittsburgh, PA). BTA (3-oxo-3-(4-(trifluoromethyl)phenyl)propanenitrile) was purchased

February 15, 2025

The Bulletin Of Tokyo Dental College

Kokubu, E;Ando, Y;Kikuchi, Y;Yonezawa, H;Ishihara, K;

Product: LPS from Escherichia coli O55:B5

Escherichia coli O55:B5 LPS List biological labs

February 12, 2025

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)

Li, Q;Park, J;Kim, JS;Le, QV;Lee, J;Oh, YK;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

ogenizer (Qiagen, Hilden, Germany). The emulsified MOG peptides were administered subcutaneously at a dose of 200 µg per mouse. In addition, 400 ng of pertussis toxin (List Biological Labs, Campbell, CA) was intraperitoneally administered 2 and 24 h after emulsion injection

February 11, 2025

Medrxiv

Jansen, A;Bruse, N;Waalders, N;Lier, D;Leijte, G;Gerretsen, J;Adriaansen, B;Herwaarden, T;Pickkers, P;Kox, M;

Product: LIST™ HPT™ from Escherichia coli O113

/ 0.45% sodium chloride in 45 minutes) were administered to reduce the risk of vasovagal responses 49 292 . Thereafter, a 293 bolus of 1 ng/kg LPS (E. coli Type O113, Lot no. 94332B1; List Biological Laboratories, Campbell, USA)

February 8, 2025

Biorxiv

Khalil, M;Gurski, C;Burns, R;Zander, R;Sommers, K;Beltrame, A;Dittel, B;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

PB peptide Ac1-11 (300 µg) 374 emulsified in complete Freunds adjuvant (Condrex, Inc, Woodinville, WA) with pertussis toxin 375 (300 ng) (List Biological Laboratories, Campbell, CA) administered intraperitoneally on days 0 376 and 2. Clinical signs of EAE were scored daily as follows: 0, no disease; 1, lim

February 8, 2025

Neuroscience

Wang, H;Wu, S;Lu, J;Su, Y;Wang, J;Wang, Y;Xu, D;Liu, Y;Gao, J;Bai, W;Cui, J;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

ons following LPC injection. On days 0, 7, 14, and day 28 post-LPC injection, 0.5 ?L of 1 % CTB (Cat# 104, List Biological Labs, Campbell, CA, USA) was carefully injected. The injection targeted a site 10 mm distal to the ischiatic notch and was performed in three rats

February 8, 2025

Molecular Neurodegeneration

Attwell, CL;Maldonado-Lasunción, I;Eggers, R;Bijleveld, BA;Ellenbroek, WM;Siersema, N;Razenberg, L;Lamme, D;Fagoe, ND;van Kesteren, RE;Smit, AB;Verhaagen, J;Mason, MRJ;

Product: Anti-Cholera Toxin B Subunit (Goat)

Three days before perfusion, all animals were anesthetized with isoflurane and the left sciatic nerve was exposed. Animals were injected with 3 µl cholera toxin subunit B (CTB; 10 mg/ml) (103B, List Laboratories Inc., Campbell, CA) in the sciatic nerve to transganglionically label ascending dorsal column axons in the spinal cord. To visualize TF expression from AAV vectors at the time-point;xed with 4% PFA for 5 min and blocked with blocking medium (2% horse serum, 0.2% triton X100 in 1xTBS) for 1 h. Primary antibodies were as follows. Goat anti-CTB (1:100,000 with 72 h incubation) (List BIological Laboratories); rabbit anti-GFP (1:1000, Abcam; ab290); mouse anti-GFAP (1:4000, Sigma G3893). Secondary antibodies were: biotinylated horse anti-goat (1:300, Vector Laboratories); donk ... . Three days before perfusion, all animals were anesthetized with isoflurane and the left sciatic nerve was exposed. Animals were injected with 3 µl cholera toxin subunit B (CTB; 10 mg/ml) (103B, List Laboratories Inc., Campbell, CA) in the sciatic nerve to transganglionically label ascending dorsal column axons in the spinal cord. To visualize TF expression from AAV vectors at the time-point ... xed with 4% PFA for 5 min and blocked with blocking medium (2% horse serum, 0.2% triton X100 in 1xTBS) for 1 h. Primary antibodies were as follows. Goat anti-CTB (1:100,000 with 72 h incubation) (List BIological Laboratories); rabbit anti-GFP (1:1000, Abcam; ab290); mouse anti-GFAP (1:4000, Sigma G3893). Secondary antibodies were: biotinylated horse anti-goat (1:300, Vector Laboratories); donk

February 7, 2025

Journal Of Nanobiotechnology

Tang, W;Huang, X;Yi, YD;Cao, F;Deng, M;Fan, J;Jiang, ZX;Tao, LM;Wang, X;Shi, L;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

he adult retinal pigment epithelial cell line-19 (ARPE-19). Human IRBP (peptide 1169-1191) was supplied by Sangon Bioengineering Co., Ltd. (Shanghai, China). Pertussis toxin (PTX) was obtained from List Biological Labs, Inc. (Campbell, California, USA). Beyotime Biotechnology Co. Limited (Shanghai, China) supplied the superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), glutathione ... he adult retinal pigment epithelial cell line-19 (ARPE-19). Human IRBP (peptide 1169-1191) was supplied by Sangon Bioengineering Co., Ltd. (Shanghai, China). Pertussis toxin (PTX) was obtained from List Biological Labs, Inc. (Campbell, California, USA). Beyotime Biotechnology Co. Limited (Shanghai, China) supplied the superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), glutathione

Bacterial Toxin Research Citations

Microbial metabolism of food allergens determines the severity of IgE-mediated anaphylaxis

K27-linked ROR?t ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity

Benzoylacetonitrile as a novel anti-inflammatory compound on attenuating microglia and encephalitogenic T cell activation in experimental autoimmune encephalomyelitis

Treponema Denticola Activates NF-?B Pathway via Toll-like Receptor 2

Anti-Inflammatory Macrophage-Derived Exosomes Modified With Self-Antigen Peptides for Treatment of Experimental Autoimmune Encephalomyelitis

Sexual dimorphism during LPS-induced systemic inflammation

Overexpression of GITRL by B cell IgD low (BDL) B cells is a therapeutic strategy to increase endogenous CD4+Foxp3+ T regulatory cells for the treatment of autoimmunity

Changes in sensory and motor neurons populations following LPC-induced sciatic nerve demyelination in rats: A study using CTB retrograde tracing

The transcription factor combination MEF2 and KLF7 promotes axonal sprouting in the injured spinal cord with functional improvement and regeneration-associated gene expression

Hyaluronic acid-curcumin nanoparticles for preventing the progression of experimental autoimmune uveitis through the Keap1/Nrf2/HO-1 signaling pathway